Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

The results are an uncomfortable echo of late October 2024, when Mounjaro and Zepbound missed by similar margins. Those ...

If you have questions about how to use Zepbound, talk with your doctor or pharmacist. There’s also a helpful video and step-by-step instructions on the manufacturer’s website. Injection site ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could ... drug insurance plan,” the drugmaker says on its web site. “If you have commercial drug insurance with coverage for Zepbound ...

Following positive results from its SURMOUNT-5 trial, Eli Lilly’s Zepbound (tirzepatide) will surpass Novo Nordisk’s Weogvy (semaglutide) in the obesity treatment market, according to a ...

The FDA says side effects for Zepbound include nausea, diarrhea, vomiting, constipation, stomach pain, reactions at the injection site, fatigue, allergic reactions, burping, hair loss and ...